scholarly article | Q13442814 |
P50 | author | Harry Malech | Q42654598 |
P2093 | author name string | Elizabeth M Kang | |
Kyu Lee Han | |||
Seung-Kwon Ha | |||
Cattlena M Changpriroa | |||
Sherry M Koontz | |||
Stephenie V M Thomas | |||
P2860 | cites work | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
Adenosine A2A receptor agonists as anti-inflammatory agents | Q28242079 | ||
Adenosine A2A agonists in development for the treatment of inflammation | Q28261970 | ||
Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways | Q28511859 | ||
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells | Q30435569 | ||
Adenosine in tissue protection and tissue regeneration | Q30435890 | ||
Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 | ||
Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy | Q30438880 | ||
Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction | Q30440124 | ||
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 | ||
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 | ||
Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation | Q33615249 | ||
Current and future approaches for control of graft-versus-host disease | Q33642625 | ||
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 | ||
A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease | Q34312261 | ||
CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease | Q34525987 | ||
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation | Q34561047 | ||
Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. | Q34896844 | ||
Cytokines, viruses, and graft-versus-host disease | Q34977543 | ||
Pathophysiology of acute graft-versus-host disease | Q35634710 | ||
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease | Q35848458 | ||
Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease | Q35995245 | ||
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID | Q36185196 | ||
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells | Q36496998 | ||
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Q36693820 | ||
Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells | Q36831117 | ||
Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation | Q36904078 | ||
Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting? | Q37116728 | ||
Donor reactive regulatory T cells | Q37485835 | ||
Adenosine receptors and inflammation | Q37565170 | ||
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides | Q39797150 | ||
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 | ||
Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice | Q42109680 | ||
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention | Q44641693 | ||
Graft-versus-host disease prevention by rapamycin: cellular mechanisms | Q46600793 | ||
Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. | Q53072852 | ||
Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. | Q53557826 | ||
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo. | Q53558142 | ||
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue | Q61762159 | ||
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine | Q72028809 | ||
Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat ad | Q73574475 | ||
The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study | Q78812754 | ||
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells | Q79919091 | ||
Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma | Q80135176 | ||
The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation | Q81261229 | ||
Can Treg therapy prevent GVHD? | Q83253234 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 458-468 | |
P577 | publication date | 2012-12-07 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease | |
P478 | volume | 190 |
Q26749571 | A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment |
Q37710715 | A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development. |
Q28075204 | Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives |
Q33878542 | Extracellular adenosine-mediated modulation of regulatory T cells |
Q34047834 | Extracellular nucleotide and nucleoside signaling in vascular and blood disease |
Q28080809 | Graft versus host disease: New insights into A2A receptor agonist therapy |
Q36070609 | PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-β1 Pathway |
Q90245668 | Pharmacological preconditioning with adenosine A1 receptor agonist induces immunosuppression and improves graft survival in novel allogeneic transplantation models |
Q38753350 | Purinergic regulation of the immune system |
Q38263455 | Purinergic signalling and immune cells |
Q38843185 | Safety issues of compounds acting on adenosinergic signalling |
Q90400275 | Special Issue: G Protein-Coupled Adenosine Receptors: Molecular Aspects and Beyond |
Q28068647 | The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease |
Q51737095 | [Rapamycin affect the apoptosis of splenic CD4+CD25+ regulatory T cells of mouse severe aplastic anemia model]. |